Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Noguera

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Cancers|October 14, 2020
Potential Molecular Players of the Tumor Microenvironment in Extracranial Pediatric Solid TumorsRosa Noguera, Álvaro Naranjo
Molecular & Cellular Oncology|June 17, 2016
Diagnostic implications of intrapatient genetic tumor heterogeneityAna P Berbegall, Samuel Navarro, Rosa Noguera
Seminars in Diagnostic Pathology|December 30, 2006
GIST: particular aspects related to cell cultures, xenografts, and cytogeneticsJosé Antonio López-Guerrero, Rosa Noguera, Antonio Llombart-Bosch
Human Pathology|August 7, 2009
Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomasManish Mani Subramaniam, Marta Piqueras, Samuel Navarro, et al.
Histopathology|June 15, 2011
Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell contentMarta Piqueras, Samuel Navarro, Adela Cañete, et al.
Expert Review of Neurotherapeutics|March 8, 2016
Genetic features of neuroblastic tumors associated with opsoclonus-myoclonus syndrome opens up the possibility for detection in peripheral bloodAna P Berbegall, Ricardo López-Almaraz, Samuel Navarro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 19, 2005
[Neuroblastoma]Victoria Castel, Adela Cañete, Rosa Noguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Circulating MYCN DNA predicts MYCN-amplification in neuroblastomaValérie Combaret, Christophe Bergeron, Rosa Noguera, et al.
BMC Cancer|May 24, 2019
Vitronectin as a molecular player of the tumor microenvironment in neuroblastomaRebeca Burgos-Panadero, Inmaculada Noguera, Adela Cañete, et al.
Pediatric Blood & Cancer|January 26, 2017
A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumorsIrene Tadeo, Ana P Berbegall, Samuel Navarro, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Cancers|October 14, 2020
Potential Molecular Players of the Tumor Microenvironment in Extracranial Pediatric Solid TumorsRosa Noguera, Álvaro Naranjo
Molecular & Cellular Oncology|June 17, 2016
Diagnostic implications of intrapatient genetic tumor heterogeneityAna P Berbegall, Samuel Navarro, Rosa Noguera
Seminars in Diagnostic Pathology|December 30, 2006
GIST: particular aspects related to cell cultures, xenografts, and cytogeneticsJosé Antonio López-Guerrero, Rosa Noguera, Antonio Llombart-Bosch
Human Pathology|August 7, 2009
Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomasManish Mani Subramaniam, Marta Piqueras, Samuel Navarro, et al.
Histopathology|June 15, 2011
Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell contentMarta Piqueras, Samuel Navarro, Adela Cañete, et al.
Expert Review of Neurotherapeutics|March 8, 2016
Genetic features of neuroblastic tumors associated with opsoclonus-myoclonus syndrome opens up the possibility for detection in peripheral bloodAna P Berbegall, Ricardo López-Almaraz, Samuel Navarro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 19, 2005
[Neuroblastoma]Victoria Castel, Adela Cañete, Rosa Noguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Circulating MYCN DNA predicts MYCN-amplification in neuroblastomaValérie Combaret, Christophe Bergeron, Rosa Noguera, et al.
BMC Cancer|May 24, 2019
Vitronectin as a molecular player of the tumor microenvironment in neuroblastomaRebeca Burgos-Panadero, Inmaculada Noguera, Adela Cañete, et al.
Pediatric Blood & Cancer|January 26, 2017
A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumorsIrene Tadeo, Ana P Berbegall, Samuel Navarro, et al.
Pageof 13